Physician profile
David E Greene
NPI 1336189547
$787.55
in general payments reported to CMS, 2019-2025
16 companies · $236 in 2025
The $236 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $92.96 · 2022: $63.17 · 2023: $141 · 2024: $255 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $545 · Education: $85.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $545.43 |
| Education | $85.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $162.26 | 2023-2025 | Polivy, Columvi, Venclexta |
| Tactile Systems Technology INC | $113.08 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Intercept Pharmaceuticals, INC. | $98.42 | 2021-2022 | |
| Aveo Pharmaceuticals, INC. | $85.99 | 2025 | |
| Mirati Therapeutics, INC. | $52.43 | 2023 | Krazati |
| Gilead Sciences, INC. | $36.81 | 2024-2025 | Trodelvy |
| Amgen INC. | $36.00 | 2023 | Blincyto |
| Astellas Pharma US INC | $32.38 | 2025 | Vyloy |
| Beone Medicines USA, INC. | $29.35 | 2025 | Brukinsa |
| Pfizer INC. | $23.27 | 2024 | |
| Array Biopharma INC | $21.32 | 2024 | Braftovi, Lorbrena, Mektovi |
| Servier Pharmaceuticals LLC | $21.29 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $20.79 | 2025 | Lynparza |
| Janssen Biotech, INC. | $20.12 | 2021 | |
| Tolmar, INC. | $17.74 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.